LEE'S SUMMIT, Mo., Sept. 13, 2018 /PRNewswire/ -- Viracor Eurofins announced the addition of a new cytomegalovirus (CMV) gene sequencing assay for resistance to letermovir, the most recent ...
Takeda is closing on a first FDA approval in the treatment of refractory cytomegalovirus (CMV) infections in organ transplant patients, after agency advisors voted unanimously in favour of its ...
KANSAS CITY, Mo.--(BUSINESS WIRE)--ViraCor Laboratories, the leader in molecular diagnostic testing for infectious diseases, today announced the launch of a new cytomegalovirus (CMV) antiviral ...
Risk factors for ganciclovir-resistant CMV include D+/R- pairing, high CMV viral load, high level of immunosuppression (ie, use of antilymphocyte antibodies), and prolonged ganciclovir exposure. A ...
Credit: Getty Images. Maribavir is an orally bioavailable anti-CMV compound that targets and inhibits the UL97 protein kinase and its natural substrates. Maribavir is an orally bioavailable anti-CMV ...
Dorothy M. M. Kersten Professor of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio; Medical Director, Liver Transplantation Program, Cincinnati Children's Hospital Medical ...
Organ and hematopoietic stem cell transplants (HSCTs) are life-saving treatments, but come with certain risks, like viral infection. Because some degree of immune suppression is required for the ...
Please provide your email address to receive an email when new articles are posted on . According to a recent study, letermovir led to clinical improvements in patients when used as salvage treatment ...
With Gift Aid, your generous donation of £10 would be worth £12.50 at no extra cost to you. Yes, I want to Gift Aid any donations made to NAM now, in the future and in the past four years I am a UK ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results